Market News / Story
HAE, PCRX Stocks Hit Multi-Year Highs Amid Broader Market Selloff – What’s Driving The Momentum Today?
Stocktwits ·
Stocktwits reports: Shares of Pacira BioSciences (PCRX) and Haemonetics (HAE) surged to multi-year highs on Thursday, driven by major business developments and bullish Wall Street calls. Pacira rallied after Viatris (VTRS) announced a $1.65 billion takeover deal, while Haemonetics shares surged after it expanded its partnership with CSL Plasma. HAE shares surged over 17% to their highest level since March 2021, while PCRX stock soared 44% to its highest level since September 2023. JPMorgan…
Related stories
What can we expect from the UK Budget later this month?Read story summary
Overnight we saw the first real leak of the plans that UK Chancellor John Healey has for his Budget later this month. FT Exclusive: Higher borrowing costs and rising inflation are likely to have slashed chancellor John Healey’s headroom in half, according to FT estimates, forcing him to lean on Budget tax rises and spending cuts to ease living costs…..Iran ...
VIEW SOURCE
Higher bond yields are raising the bar for stocks: Stan WongRead story summary
For much of this year, “higher for longer” was a warning. Now it is a market reality. With the U.S. 10-year Treasury yield above 5.25 per cent and touching a two-decade high, borrowing costs are becoming harder for markets to ignore. Bonds also compete more directly with equities for investor capital. The implications for equity valuations are significant. ...
VIEW SOURCE